Allogeneic Versus Autologous Bone Marrow Transplantation for Refractory and Recurrent Low-Grade Non-Hodgkin's Lymphoma: Updated Results of the Utrecht Experience-Reference-Cited by-同舟云学术

Allogeneic Versus Autologous Bone Marrow Transplantation for Refractory and Recurrent Low-Grade Non-Hodgkin's Lymphoma: Updated Results of the Utrecht Experience

Published:1999-01 Issue:1-2 Volume:34 Page:129-136
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Verdonck Leo F.¹

Affiliation:

1. From the Department of Haematology, University Hospital, Utrecht, The Netherlands

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428199909083388

Reference24 articles.

1. Treatment approaches to the low-grade lymphomas

2. Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nouvelle approche thérapeutique complémentaire par des mobilisateurs naturels de cellules souches dans les processus de régénération et de réparation;Hegel;2020-04-01

2. Comparison of Survival Between Autologous and Allogeneic Stem Cell Transplantation in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Meta-Analysis;Cell Transplantation;2020-01-01

3. Outcome Comparison of Allogeneic versus Autologous Stem Cell Transplantation in Transformed Low-Grade Lymphoid Malignancies: A Systematic Review and Pooled Analysis of Comparative Studies;Acta Haematologica;2016

4. Tale of Two Lymphomas: Peripheral T-Cell Lymphoma After Allogeneic Stem-Cell Transplantation for Marginal Zone Lymphoma;Journal of Clinical Oncology;2012-11-01

5. Infusing CD19-Directed T Cells to Augment Disease Control in Patients Undergoing Autologous Hematopoietic Stem-Cell Transplantation for Advanced B-Lymphoid Malignancies;Human Gene Therapy;2012-05